A hallucinogenic drug known on the street as “Special K” offers new hope to those suffering from severe, treatment-resistant depression.
Ketamine, which was originally developed in the 1960s as a milder version of PCP, already has a well-established medical use as a sedative or pain killer. But since 2000, small but high-quality studies have demonstrated its uses as a powerful and fast-acting treatment for major depression.